RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Cardiotoxicity
Accession: DOID:9002371
browse the term
Definition: Damage to the heart or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
Synonyms: exact_synonym: Cardiac Toxicities; Cardiac Toxicity; Cardiotoxicities
primary_id: MESH:D066126
xref: EFO:1001482
G
ACACB
acetyl-CoA carboxylase beta
ISO
mRNA, protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr26:17,763,531...17,895,319
Ensembl chr26:17,747,362...17,894,400
G
AGT
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33676887
NCBI chr 4:8,681,192...8,694,059
Ensembl chr 4:8,683,798...8,693,880
G
BCHE
butyrylcholinesterase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26145887
NCBI chr34:30,912,632...30,977,624
Ensembl chr34:30,912,632...30,977,583
G
BMP2
bone morphogenetic protein 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29800642
NCBI chr24:15,199,667...15,211,509
Ensembl chr24:15,200,291...15,212,217
G
CAT
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35792220
NCBI chr18:33,383,005...33,422,447
Ensembl chr18:33,383,005...33,422,447
G
CCL2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 9:39,008,187...39,009,932
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
mRNA, protein:decreased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr18:49,136,691...49,190,117
Ensembl chr18:49,136,691...49,190,117
G
CSF1
colony stimulating factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr 6:42,028,454...42,047,028
Ensembl chr 6:42,034,149...42,049,371
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr13:62,435,035...62,438,354
Ensembl chr13:62,434,422...62,438,354
G
FAS
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr26:38,738,811...38,763,298
Ensembl chr26:38,737,611...38,763,321
G
FASLG
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34713381
NCBI chr 7:26,335,837...26,344,224
Ensembl chr 7:26,335,846...26,344,224
G
FTO
FTO alpha-ketoglutarate dependent dioxygenase
ISO
DNA:hypermethylation:promoter
RGD
PMID:35462195
RGD:329951017
NCBI chr 2:61,699,864...62,080,199
Ensembl chr 2:61,652,236...62,080,059
G
HBEGF
heparin binding EGF like growth factor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr 2:35,551,248...35,563,310
Ensembl chr 2:35,551,250...35,563,043
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32068018
NCBI chr17:37,019,329...37,033,388
Ensembl chr17:37,019,329...37,024,458
G
KCNN2
potassium calcium-activated channel subfamily N member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:32909839 PMID:33887967
NCBI chr11:4,279,362...4,423,080
Ensembl chr11:4,154,746...4,423,078
G
METTL14
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34648132
NCBI chr32:37,653,163...37,679,577
Ensembl chr32:37,653,035...37,678,398
G
MIR143
microRNA mir-143
ameliorates
ISO
RGD
PMID:32170053
RGD:155883163
NCBI chr 4:59,534,535...59,534,589
Ensembl chr 4:59,534,535...59,534,594
G
MIR208A
microRNA mir-208a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26454886
NCBI chr 8:3,636,919...3,636,987
Ensembl chr 8:3,636,919...3,636,987
G
MLYCD
malonyl-CoA decarboxylase
ISO
protein:increased expression:heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 5:68,385,058...68,399,965
Ensembl chr 5:68,384,618...68,399,965
G
NOS3
nitric oxide synthase 3
treatment
ISO
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human)
RGD
PMID:26345518
RGD:11533645
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
G
NPPB
natriuretic peptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr 2:84,395,844...84,397,473
G
NRG1
neuregulin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29305325
NCBI chr16:31,697,958...32,771,888
Ensembl chr16:31,706,851...32,771,932
G
PRKAA2
protein kinase AMP-activated catalytic subunit alpha 2
ISO
protein:decreased expression:serum, heart (rat)
RGD
PMID:30644033
RGD:329955369
NCBI chr 5:52,809,792...52,855,072
Ensembl chr 5:52,815,609...52,876,609
G
RAC1
Rac family small GTPase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28710503
NCBI chr 6:11,726,259...11,758,532
Ensembl chr 6:11,655,494...11,757,216
G
RARG
retinoic acid receptor gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26237429
NCBI chr27:1,958,432...1,978,471
Ensembl chr27:1,958,204...1,978,476
G
RNF10
ring finger protein 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36740146
NCBI chr26:16,426,220...16,461,478
Ensembl chr26:16,426,234...16,547,119
G
SIRT6
sirtuin 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34713381
NCBI chr20:55,412,989...55,424,944
Ensembl chr20:55,412,646...55,424,944
G
TLR2
toll like receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987
NCBI chr15:51,454,557...51,465,429
Ensembl chr15:51,454,695...51,465,241
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29959987 PMID:32068018
NCBI chr12:1,074,561...1,076,425
Ensembl chr12:1,074,552...1,076,425
G
TP53
tumor protein p53
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30009776 PMID:34713381
NCBI chr 5:32,561,406...32,565,149
Ensembl chr 5:32,560,598...32,574,109
G
ABCB1
ATP binding cassette subfamily B member 1
susceptibility
ISO
DNA:missense mutation:cds:p.G671V (human)
RGD
PMID:16330681
RGD:11041175
NCBI chr14:13,644,891...13,852,829
Ensembl chr14:13,542,647...13,742,727
G
ACVR2B
activin A receptor type 2B
treatment
ISO
human construct in mouse model
RGD
PMID:30765322
RGD:329849112
NCBI chr23:8,211,555...8,225,596
Ensembl chr23:8,192,483...8,218,894
G
CAPN2
calpain 2
treatment
ISO
RGD
PMID:25634181
RGD:13792617
NCBI chr 7:40,333,379...40,367,158
Ensembl chr 7:40,334,012...40,377,037
G
ERCC2
ERCC excision repair 2, TFIIH core complex helicase subunit
ISO
associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human)
RGD
PMID:24284041
RGD:11252190
NCBI chr 1:110,173,781...110,191,612
Ensembl chr 1:110,173,715...110,190,125
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all